Over 60 novel drug candidates are in late-stage clinical trials in China, and these will potentially compete directly with US ...

Credit: Teva. The generic product is supplied in a prefilled, single-patient-use pen. Teva has launched an authorized generic version of Victoza ® (liraglutide injection). Liraglutide is a ...

The generic product is supplied in a prefilled, single-patient-use pen. Teva has launched an authorized generic version of Victoza ® (liraglutide injection).

The US Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals), a glucagon-like peptide-1 (GLP-1) receptor agonist indicated to improve ...

In fact, Android Authority has uncovered what the Pixel Pen looked like, which was basically a generic USI 2.0 Stylus. Which makes it even more interesting as to why Google didn’t release it.

The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.

Amneal has received approval from the Food and Drug Administration for exenatide, which is the company’s first generic injectable glucagon-like peptide-agonist and reflects its innovation ...

Growth is driven by the rising prevalence of diabetes among the elderly, necessitating efficient insulin delivery solutions like pen needles, due to their user-friendly design and minimal discomfort.

Exenatide belongs to a group of drugs called glucagon-like peptide-1 (GLP-1) agonists. Bydureon BCise comes as a liquid suspension that you’ll inject under your skin with a prefilled pen.

Amphastar saw yearly EPS rise by 39.2%. The company expects low-blood-sugar medicine glucagon will drive sales this year, along with new launches. Amphastar is also seeing a strong increase in ...

Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, its First Generic Injectable GLP-1 Agonist ...

In fact, Android Authority has uncovered what the Pixel Pen looked like, which was basically a generic USI 2.0 Stylus. Which makes it even more interesting as to why Google didn’t release it.